Literature DB >> 27899193

Genetic predisposition to leukemia and other hematologic malignancies.

Simone Feurstein1, Michael W Drazer2, Lucy A Godley3.   

Abstract

In this review, we provide an overview of familial myelodysplastic syndromes (MDS)/acute leukemia (AL) and bone marrow failure syndromes, as well as insights into familial myeloproliferative neoplasms (MPNs), familial multiple myeloma (MM), familial Waldenström macroglobulinemia (WM), familial lymphoma, and cancer predisposition syndromes with increased risk of MDS/AL. This field will continue to accelerate as next-generation sequencing (NGS) techniques identify novel predisposition alleles in families with a genetic predisposition to hematologic malignancies. Newly identified predisposition genes continue to inform the field of inherited leukemia and other hematologic malignancies. Current developments in clinical translation include techniques detailing the acquisition of appropriate germline material for patient work-ups, methods for genetic testing, and nuances essential for the treatment and clinical management of patients with a genetic predisposition to hematologic malignancies. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Familial leukemia; Genetic risk

Mesh:

Year:  2016        PMID: 27899193     DOI: 10.1053/j.seminoncol.2016.10.003

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  22 in total

1.  Accurate germline RUNX1 variant interpretation and its clinical significance.

Authors:  Simone Feurstein; Liying Zhang; Courtney D DiNardo
Journal:  Blood Adv       Date:  2020-12-22

Review 2.  Ethical considerations in genomic testing for hematologic disorders.

Authors:  Jonathan M Marron; Steven Joffe
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

Review 3.  Genetic predisposition to MDS: clinical features and clonal evolution.

Authors:  Alyssa L Kennedy; Akiko Shimamura
Journal:  Blood       Date:  2019-01-22       Impact factor: 22.113

4.  Buccal epithelial cells display somatic, bone marrow-derived CALR mutation.

Authors:  Scott R Gilles; Linda B Baughn; Matthew L Schomaker; Elizabeth L Courville; Andrew C Nelson; Zohar Sachs
Journal:  Blood Adv       Date:  2017-11-16

5.  Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?

Authors:  Felicitas Thol; Uwe Platzbecker
Journal:  Blood Adv       Date:  2019-11-12

6.  Predisposition to childhood acute lymphoblastic leukemia caused by a constitutional translocation disrupting ETV6.

Authors:  Tekla Järviaho; Benedicte Bang; Vasilios Zachariadis; Fulya Taylan; Jukka Moilanen; Merja Möttönen; C I Edvard Smith; Arja Harila-Saari; Riitta Niinimäki; Ann Nordgren
Journal:  Blood Adv       Date:  2019-09-24

Review 7.  Germline ETV6 mutations and predisposition to hematological malignancies.

Authors:  Simone Feurstein; Lucy A Godley
Journal:  Int J Hematol       Date:  2017-05-29       Impact factor: 2.490

Review 8.  Diagnosis and classification of hematologic malignancies on the basis of genetics.

Authors:  Justin Taylor; Wenbin Xiao; Omar Abdel-Wahab
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

Review 9.  Genetic predisposition to hematologic malignancies: management and surveillance.

Authors:  Lucy A Godley; Akiko Shimamura
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

Review 10.  Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies.

Authors:  Imo J Akpan; Afaf E G Osman; Michael W Drazer; Lucy A Godley
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.